Please find enclosed herewith the outcome of Nomination and Remuneration Committee meeting held today i.e. on May 12, 2026, the members has granted 1,80,000 stock options under Bliss GVS ....
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Nomination and Remuneration Committee of Bliss GVS Pharma Ltd granted 1,80,000 stock options to eligible employees on May 12, 2026. Each option, convertible into one equity share of Re. 1/- face value, carries an exercise price of Rs. 43/- per share. This price reflects an 84.20% discount to the NSE closing price on May 11, 2026, set to align with earlier option grants. Options vest over four equal tranches (25% each) at 12, 24, 36, and 48 months from the grant date. Vested options must be exercised within 6 months, and resulting shares face a 6-month lock-in period from allotment. This is a routine ESOP grant under the company's 2019 employee compensation plan, compliant with SEBI SBEB regulations.
The 84.20% discounted exercise price reflects a significant employee benefit, which may create future dilution for shareholders as options vest and are exercised. The announcement signals management's effort to retain and incentivize employees but carries no immediate impact on the stock price.